Alex successfully applied for an Irish Cancer Society international mobility element, which afforded her the opportunity to spend three months in the Albert Einstein College of Medicine, New York. She was mentored by an expert in the field of Epigenetics, Prof John Greally, in order to learn how to computationally catalogue enhancer activity in prostate cancer.
-
Cancer Research News- Researchers uncover new role of mutant RAS proteins in some of the deadliest cancers November 11, 2024
- NIH-funded scientists uncover clues to precancer and tumor biology October 30, 2024
- NIH clinical trial will test precision medicine treatments for myeloid cancers October 23, 2024
- New cancer diagnoses did not rebound as expected following pandemic September 24, 2024
- Immunotherapy after surgery helps people with high-risk bladder cancer live cancer-free longer September 16, 2024
- NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry September 16, 2024
- Immunotherapy approach shows potential in some people with metastatic solid tumors July 11, 2024
- For healthy adults, taking multivitamins daily is not associated with a lower risk of death June 26, 2024
- Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma June 19, 2024
- Inherited genetic factors may predict the pattern of X chromosome loss in older women June 12, 2024